China News Service, September 16th, a comprehensive report that the delta strain continues to rages in the United States, and the country has encountered a severe "milestone" in the fight against the new crown epidemic: The number of deaths from the new crown in the United States exceeds 660,000, which is equivalent to every 500 Americans. 1 person died of the new crown.

US media said that this is a sobering number.

On the other hand, the Biden administration in the United States plans to start distributing vaccine boosters to the general population next week. Pfizer Vaccine also said that the effectiveness of the vaccine will weaken over time, and it is recommended that the public be given booster shots.

On October 4, 2020, local time, in Washington, the capital of the United States, 20,000 chairs were placed on the lawn on the south side of the White House to mourn the deaths of more than 200,000 new crowns in the United States.

Another severe "milestone" in the United States!

1 out of 500 people die from the new crown

　　According to US media reports, the United States has encountered another severe "milestone" in the fight against the devastating new crown epidemic: Since the country first reported confirmed cases of new crowns, more than 660,000 people have died from the new crown, which is equivalent to every 500 people. One in Americans has died from the new coronavirus.

　　According to data from Johns Hopkins University, as of the evening of the 14th, 663,913 people in the United States have died from the new crown.

According to data from the US Census Bureau, as of April 2020, the US population is 331.4 million.

　　US media said that this is a sobering number, because American hospitals are struggling to cope with the number of new crown patients, and more and more children are fighting the new crown virus.

Since early summer, the mortality rate has risen sharply due to the highly contagious delta variant becoming mainstream.

　　According to data from Johns Hopkins University, as of the 14th, in the past week, the average number of new cases per day in the United States exceeded 152,300, which is more than 13 times the lowest average of June 22 (11,303 cases per day) in 2021. .

The United States has an average of 1,805 new crown deaths every day during a week, which is far higher than the lowest average of this year (218 cases) reached on July 5th.

　　In addition, as the school season begins in various parts of the United States, the number of child infections in the country has surged, causing concern.

Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said on the 14th that the combination of masks and vaccination is a way to keep children in school.

Pfizer says vaccine effectiveness diminishes over time

Can the US FDA approve the booster injection?

　　On the other hand, the Biden administration plans to start distributing vaccine boosters to the general population on the 20th, but it is still doubtful whether the US regulator will approve this measure.

　　On the 15th, the US Food and Drug Administration (FDA) staff refused to express a position on whether to support Pfizer Booster, saying that it has not verified all existing data.

　　The FDA also announced the latest data submitted by Pfizer on the 15th.

In this report, Pfizer showed evidence that the third dose of the vaccine is safe for most Americans.

　　Pfizer said in a 52-page report that the effectiveness of the mRNA vaccine will diminish over time, but the booster can produce an immune response similar to the second shot of the vaccine.

　　Pfizer said that real-world data from Israel shows that the third dose of vaccine can restore a high level of protection against the new coronavirus, with an effectiveness of 95%. These data were collected between July 1 and August 30, when Del Tower variants are spreading in the country.

　　The company stated that their booster application is "for people over 16 years of age" and recommends that "boost up is given approximately 6 months after the second dose of vaccine."

　　The FDA Vaccine and Biologics Advisory Committee (VRBPAC) will meet on the 17th to review the data submitted by Pfizer on its booster and vote on whether to recommend vaccination to the general public.